Completed Research Projects
Collaborative research that has advanced regulatory frameworks, policy development, and scientific understanding across biodiversity, biosafety, and biotechnology domains.
Horizon 2020
MICRO4BIOGAS
The Micro4Biogas project was dedicated to advancing the biogas sector in Europe by optimizing biogas production by combining selected natural and synthetic microbial strains and consortia. Recognizing the urgent need to shift from polluting fossil fuels to renewable energy sources, the project aimed to significantly increase the yield, speed, quality, and reproducibility of biogas production. The project's innovative approach sought to establish biogas as a competitive, sustainable, and viable renewable energy option, playing a crucial role in Europe's transition towards cleaner energy solutions and addressing the global energy and climate crisis. The project concluded in 2025.
- Market research on biogas sector
- Business models & strategic planning
- Intellectual property management
Marie Curie ITN
EATFISH (European Aquaculture Training & Fish Genetics)
EATFISH, supported by the EU's Marie Skłodowska–Curie program, was a pioneering project with the aim of transforming European aquaculture into a sustainable and profitable industry. As an interdisciplinary project, EATFISH trained a new generation of scientists in sustainable aquaculture, addressing both environmental and consumer needs. By blending biology, technology, socioeconomics, and governance, the project aimed to optimize resource use, promote animal welfare, and develop innovative products while refining governance strategies. The project concluded in 2025.
- Innovation valorisation & value capture strategies
- Entrepreneurial skills training for Early-Stage Researchers
- Practical aquaculture industry experience
Marie Curie ITN
MARPIPE (Marine Biodiscovery Pipeline)
MARPIPE was a Marie Skłodowska-Curie consortium of 11 partners across 8 countries (Italy, Norway, UK, Germany, Belgium, Ireland, Spain, Netherlands) training 11 PhD researchers in all phases of the marine drug-discovery pipeline, from isolation of new microbial strains to pre-clinical development of lead compounds. The project advanced antimicrobial and anticancer lead compounds from deep-sea samples (5000m depth) and addressed critical bottlenecks including low yields, chemodiversity challenges, and compound toxicity. 3BIO led training on legal frameworks, ABS policy, innovation management, and entrepreneurship, ensuring researchers understood the socio-economic and regulatory context of marine biodiscovery. The project concluded in 2023.
- Complete biodiscovery pipeline (isolation to pre-clinical)
- Deep-sea antimicrobial & anticancer compounds
- ABS compliance & legal framework training
- Innovation & entrepreneurship development
FP7
PHARMASEA (Pharmacologically Active Compounds from the Sea)
PHARMASEA addressed fundamental obstacles in marine biodiscovery research, development, and commercialization through an interdisciplinary team of academic and industry researchers. The project developed a robust pipeline processing marine microbial strain collections from extreme environments (deep, cold, and hot vent habitats) to produce new compounds for health (infection, inflammation, CNS diseases), personal care, and nutrition markets. Two compounds were advanced to larger scale and pre-clinical evaluation. 3BIO addressed policy and legal challenges by bringing together practitioners, legal experts, and policy advisors to harmonize legal frameworks with practical solutions tailored to marine biodiscovery. The project concluded in 2017.
- Marine microbiome biodiscovery pipeline
- Extreme environment sampling (deep, vent habitats)
- Legal framework harmonization for marine ABS
- Pre-clinical compound development